More than 1,500 healthcare professionals attended the 8th Qatar Diabetes, Endocrinology, and Metabolic Conference 2024 from May 2-4, hosted by Hamad Medical Corporation's (HMC) Endocrine and Diabetes Division, Department of Medicine, and the Qatar Metabolic Institute (QMI).The conference, held in person and online with attendees and speakers from around the world, brought together local and international experts in the fields of endocrinology, obesity, and diabetes to discuss the latest research, treatments, technological advances, and preventative measures for these conditions.The event also incorporated the 3rd Qatar Diabetes and Obesity Research Symposium. World-renowned international, regional and local speakers presented and updated delegates on a diverse range of topics including advances in both type 1 and type 2 diabetes, pituitary/adrenal and thyroid disorders, obesity, osteoporosis, paediatric endocrinology, genetics, as well as highlight important research initiatives on diabetes and obesity taking place in Qatar.Dr Mahmoud Ali Zirie, chair of the organising committee and clinical director of National Diabetes Centre, HMC, said the conference provided an opportunity to share the important work being done in Qatar and to deliver real results for the community.Prof Abdul Badi Abou Samra, director, QMI, said the event provided an important platform for frontline clinicians, scientists, and researchers to discuss strategies and approaches for the management and prevention of diabetes and associated conditions.“Diabetes is a complex condition which can lead to debilitating long-term complications and acute illness. The disease in Qatar is quite prevalent with about 17% of Qatar's adult population thought to have diabetes. About 20% of Qatar's population is estimated to be pre-diabetic,” he said. “Qatar is at the forefront of research and treatment of this condition. Earlier this year we opened the Qatar Diabetes Research Centre at Hamad Medical Corporation and also launched the landmark Qatar Diabetes Prevention Programme which are spearheading a personalised approach diabetes and its prevention.”Dr Ibrahim al-Janahi, chair of the Scientific Committee and senior consultant in Endocrine and Diabetes Division said many diabetics live with other associated complications such as high blood pressure, kidney disease, and vision impairment which require additional consideration.“It is important for the local and international medical community to meet and discuss trends, best practice, and long-term strategies for the prevention and mitigation of complications related to this disease so we can continue to provide the best care for our patients,” Dr al-Janahi added.